Foundation For Mitochondrial Medicine Inc is located in Atlanta, GA. Foundation For Mitochondrial Medicine Inc is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2018, Foundation For Mitochondrial Medicine Inc generated $96.1k in total revenue. This represents a relatively dramatic decline in revenue. Over the past 4 years, the organization has seen revenues fall by an average of (22.3%) each year. All expenses for the organization totaled $161.6k during the year ending 12/2018. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2018
Describe the Organization's Mission:
Part 3 - Line 1
TO HASTEN THE DEVELOPMENT OF EFFECTIVE TREATMENTS FOR MITOCHONDRIAL DISEASE.
Describe the Organization's Program Activity:
Part 3 - Line 4a
FMM'S MISSION IS TO SUPPORT THE DEVELOPMENT OF THE MOST PROMISING RESEARCH AND TREATMENTS FOR THE MANY, MANY FORMS OF MITOCHONDRIAL DISEASE; INCLUDING IMPROVING LIVES OF THOSE WITH DISEASE THROUGH BETTER, FASTER LESS INVASIVE DIAGNOSTICS AND TO FUND THE CURES. PRIORITIES ARE: AWARENESS FOR MITOCHONDRIAL DISEASE, ESTABLISHING PARTNERSHIPS AND CONNECTIONS TO RELATED DISEASES, FUNDING THE CURES WITH TREATMENT-ORIENTED RESEARCH.FMM'S INITIATIVES CONSISTENT OF MISSION-DRIVEN PROGRAMS AND OUTREACH TO RAISE AWARENESS FOR MITOCHONDRIAL DISEASE, HIGHLIGHT THE CONNECTION TO RELATED NEURODEGENERATIVE DISEASES WHERE MITOCHONDRIAL DYSFUNCTION IS A COMMON COMPONENT AND WHERE RESEARCH ON SUCH AN IMPORTANT CAUSAL ELEMENT CAN LEAD TO TREATMENTS FOR MULTIPLE DISEASE STATES. PROGRAMS INCLUDE BUT ARE NOT LIMITED TO: ESTABLISHMENT OF PARTNERSHIPS WITH RELATED DISEASE ORGANIZATIONS, MEDICAL INSTITUTIONS AND AFFILIATED NON-PROFITS, PATIENT ADVOCACY GROUPS WITH SIMILAR AND SYNERGISTIC MISSIONS. LOCAL, NATIONAL AND INTERNATIONAL COMMUNICATION EFFORTS INVOLVED MASS COMMUNICATION MEDIA RELATIONS, SOCIAL MEDIA AND INTERNET OUTREACH. 2017 EXPENSES WERE ALLOCATED TO THE FOLLOWING ENDEAVORS:HOPE FLIES CATCH THE CURE:HOPE FLIES CATCH THE CURE IS FMM'S SIGNATURE EVENT, A FUN-FILLED EVENING OF COCKTAILS, DINNER, DANCING AND AUCTIONS. AN ANNUAL EVENT OF FRIENDS AND FRIENDS OF FRIENDS GATHERED TO HELP PROMOTE AWARENESS FOR MITOCHONDRIAL DISEASE AND RAISE FUNDS FOR RESEARCH AND TREATMENTS. SEVERAL HUNDRED PEOPLE SUPPORT THE EVENT, WHICH HIGHLIGHTS STORIES AND TESTIMONIALS OF THE PATIENTS STRUGGLING WITH MITOCHONDRIAL DISEASE.MITOCHONDRIAL MEDICINE SOUTHEAST REGIONAL SYMPOSIUM: UNDERSTANDING MITOCHONDRIAL DISEASE AND MITOCHONDRIAL DYSFUNCTION, OPPORTUNITIES AND IMPACTS IN THE CLINIC AND LABORATORY TO ADDRESS HUMAN ENERGY PRODUCTION PROBLEMS ROOTED IN THE MITOCHONDRIA. IN PARTNERSHIP WITH THE UNITED MITOCHONDRIAL DISEASE FOUNDATION, FMM ORGANIZED AND LED A SOUTHEAST REGIONAL SYMPOSIUM TO FOCUS ON MITOCHONDRIAL DISEASE AND MITOCHONDRIAL DYSFUNCTION, WHICH IS AT THE ROOT OF DISEASES AND CONDITIONS THAT AFFECT THE YOUNG AND OLD, FROM AUTISM TO ALZHEIMER'S, IN WAYS THAT CAN RANGE FROM SUBTLE TO DEVASTATING.THE PROGRAM INCLUDED CME SESSIONS FOR SCIENTISTS, PRACTITIONERS AND HEALTH PROFESSIONALS, AS WELL AS A PATIENT AND FAMILIES' DAY FOR EDUCATION, NETWORKING AND SUPPORT. IN ADDITION, A KEYNOTE ADDRESS FROM THE ENERGY PROJECT PROVIDED A BROADER ENERGY PERSPECTIVE AS OUR MOST PRECIOUS RESOURCE. AN INTERSECTION OF BOTH SCIENCE AND HUMAN PERFORMANCE, THIS PROGRAM ENLIGHTENED, EDUCATED, INSPIRED AND UNLOCKED NEW IDEAS AND SOLUTIONS TO HUMAN ENERGY PROBLEMS FACING US ALL.CLINICAL SESSIONS SPEAKERS AND TOPICS INCLUDED:BRUCE H. COHEN, MD, COURSE CHAIR, AKRON CHILDREN'S HOSPITAL, AKRON, OH- POTENTIAL THERAPIES AND TREATMENTS FOR MITOCHONDRIAL DISEASELEON S. DURE, MD, COURSE CO-CHAIR, CHILDREN'S HOSPITAL OF ALABAMA, BIRMINGHAM, AL- PEDIATRIC NEUROLOGY AND MITOCHONDRIAL MEDICINE AT UABVICTOR DARLEY-USMAR, PHD, UNIVERSITY OF ALABAMA AT BIRMINGHAM SCHOOL OF MEDICINE, BIRMINGHAM, AL- BIOENERGETICS AND MITOCHONDRIAL MEDICINEDAVID FERRICK, AGILENT TECHNOLOGIES- BIOENERGETICS AND MITOCHONDRIAL MEDICINE MATT GOLDBERG, PHD, UNIVERSITY OF ALABAMA AT BIRMINGHAM SCHOOL OF MEDICINE, BIRMINGHAM, AL- PARKINSON'S AND MITOCHONDRIAL DYSFUNCTIONMICHIO HIRANO, MD, COLUMBIA UNIVERSITY, NEW YORK, NY- SCREENING AND EVALUATION OF MITOCHONDRIAL DISEASESSHILPA IYER, PHD, UNIVERSITY OF ARKANSAS, FAYETTEVILLE, AR- DOD FUNDING FOR STUDY OF LEIGH'S DISEASEAMEL KARAA, MD, MASSACHUSETTS GENERAL HOSPITAL, BOSTON, MA- MITOCHONDRIAL DISEASE PRIMERROBIN MORRIS, PHD, GA STATE NEUROPSYCHOLOGY, ATLANTA, GA- AUTISM AND MITOCHONDRIAL DYSFUNCTIONDIANA SHINEMAN, ALZHEIMER'S DRUG DISCOVERY FOUNDATION- ALZHEIMER'S AND MITOCHONDRIAL DYSFUNCTIONKESHAV SINGH, PHD, UNIVERSITY OF ALABAMA AT BIRMINGHAM, AL- CANCER AND MITOCHONDRIAL DYSFUNCTION
A KEY STRATEGIC INITIATIVE CONTINUES TO BE PARTNERSHIP DEVELOPMENT WITH RELATED DISEASE ORGANIZATIONS, CLINICAL CARE SETTINGS AND ACADEMIC MEDICAL CENTERS, LIKE THE ALZHEIMER'S DRUG DISCOVERY FOUNDATION, THE MICHAEL J. FOX FOUNDATION FOR PARKINSON'S RESEARCH, THE GEORGIA PARKINSON'S COALITION, THE WILKINS PARKINSON'S FOUNDATION, ABBY'S HELPING HAND AND THE UNIVERSITY OF ALABAMA AT BIRMINGHAM. EVENTS AND PROGRAMS TO PROMOTE AWARENESS FOR MITOCHONDRIAL DISEASE AND RAISE FUNDS FOR TREATMENTS AND RESEARCH ARE: HOPE FLIES WITH THE BRAVES, PARTNERS FOR THE CURES, GIVE28ON28 FOR RARE DISEASE DAY AND ONGOING WEBINARS AND INFORMATIONAL COMMUNICATIONS CALLED THE HOPE FLIES HEALTH SERIES.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Laura Stanley Executive Director | OfficerTrustee | 40 | $0 |
Chris Benecchi Director | Trustee | 1 | $0 |
Dick Boger Director | Trustee | 1 | $0 |
Daniela Campari Director | Trustee | 1 | $0 |
Todd Lacey Director | Trustee | 1 | $0 |
Anthony Soscia Director | Trustee | 1 | $0 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $0 |
Fundraising events | $93,337 |
Related organizations | $0 |
Government grants | $0 |
All other contributions, gifts, grants, and similar amounts not included above | $47,052 |
Noncash contributions included in lines 1a–1f | $0 |
Total Revenue from Contributions, Gifts, Grants & Similar | $140,389 |
Total Program Service Revenue | $0 |
Investment income | $0 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | -$8,553 |
Net Income from Fundraising Events | -$35,738 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $96,098 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $0 |
Grants and other assistance to domestic individuals. | $0 |
Grants and other assistance to Foreign Orgs/Individuals | $0 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $0 |
Compensation of current officers, directors, key employees. | $0 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $0 |
Pension plan accruals and contributions | $0 |
Other employee benefits | $0 |
Payroll taxes | $0 |
Fees for services: Management | $67,376 |
Fees for services: Legal | $0 |
Fees for services: Accounting | $0 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $0 |
Fees for services: Other | $42,575 |
Advertising and promotion | $2,200 |
Office expenses | $2,256 |
Information technology | $5,812 |
Royalties | $0 |
Occupancy | $0 |
Travel | $2,403 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $944 |
Interest | $0 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $0 |
Insurance | $1,549 |
All other expenses | $566 |
Total functional expenses | $161,590 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $0 |
Savings and temporary cash investments | $0 |
Pledges and grants receivable | $0 |
Accounts receivable, net | $0 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $0 |
Net Land, buildings, and equipment | $0 |
Investments—publicly traded securities | $0 |
Investments—other securities | $0 |
Investments—program-related | $0 |
Intangible assets | $0 |
Other assets | $0 |
Total assets | $0 |
Accounts payable and accrued expenses | $0 |
Grants payable | $0 |
Deferred revenue | $0 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $0 |
Total liabilities | $0 |
Unrestricted restricted net Assets | $0 |
Temporarily restricted net Assets | $0 |
Permanently restricted net Assets or current funds | $0 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Total net assets or fund balances | $0 |